Ginkgo Bioworks Holdings Inc expected to post a loss of 91 cents a share - Earnings Preview

Ginkgo Bioworks Holdings

03/08/2026 21:07

Ginkgo Bioworks Holdings Inc DNA.N, DNA is expected to  show a fall in quarterly revenue when it reports  results on August 5 for the period ending June 30 2026
The Boston Massachusetts-based  company is expected to report a 51.5% decrease in revenue to $24.05 million from $49.6 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Ginkgo Bioworks Holdings Inc is for a loss of 91 cents per share. 
The current average analyst rating on the shares is "sell" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and 2 "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Ginkgo Bioworks Holdings Inc is $9.00, about 11.2% above its last closing price of $8.09
This summary was machine generated August 3 at 20:07 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)